FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Amerisource Health Services Prazosin Hydrochloride Recall

Prazosin Hydrochloride, Capsules, USP, 1 mg, 100 capsules (10x10) cartons, Rx only, Dis…

Amerisource Health Services LLC · Columbus, OH

Risk level
Class II
Reported by FDA
Nov 5, 2025
Recall ID
D-0101-2026
Check your lot numberHow we source this data

Summary

Amerisource Health Services recalled Prazosin Hydrochloride starting Oct 16, 2025. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0101-2026 on Nov 5, 2025. Reason: Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit. Status: Ongoing.

Why it was recalled

Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit

Product description

Prazosin Hydrochloride, Capsules, USP, 1 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, Carton NDC 68084-996-01. Individual unit dose: NDC 68084-996-11

Lot numbers, UPCs & expiration codes

Lot #: 1023526, 1023555, Expiry: 07/31/2026

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0101-2026
Classification
Class II
Status
Ongoing
Recall initiated
Oct 16, 2025
FDA report date
Nov 5, 2025
Quantity
1,970 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Amerisource Health Services LLC

Original FDA data

Every field from FDA enforcement report D-0101-2026, exactly as published.

Show all FDA fields
City
Columbus
State
OH
Status
Ongoing
Country
United States
Event ID
97826
Address
2550 John Glenn Ave Ste A
Code information
Lot #: 1023526, 1023555, Expiry: 07/31/2026
Postal code
43217-1188
Report date
Nov 5, 2025
Product type
Drugs
Recall number
D-0101-2026
Classification
Class II
Recalling firm
Amerisource Health Services LLC
Product quantity
1,970 cartons
Reason for recall
Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin impurity C above the Carcinogenic Potency Categorization Approach (CPCA) acceptable intake limit
Voluntary / mandated
Voluntary: Firm initiated
Product description
Prazosin Hydrochloride, Capsules, USP, 1 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Packaging, Columbus, Ohio 43217, Carton NDC 68084-996-01. Individual unit dose: NDC 68084-996-11
Distribution pattern
Nationwide within the United States
Recall initiation date
Oct 16, 2025
Initial firm notification
Letter
Center classification date
Oct 24, 2025

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0101-2026, published Nov 5, 2025. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls